6 Results for: created: (01/2018 to 01/2018)

People

  1. Young
    Young
  2. Mellinghoff
    Mellinghoff
  3. Daras
    Daras
  4. Ahn
    Ahn
  5. Arbour
    Arbour
  6. Beal
    Beal
  7. Hayes
    Hayes
  8. Kris
    Kris
  9. Lee
    Lee
  10. Nevel
    Nevel

Groups

  1. Neuroradiology Service (6)
  2. Radiology, Department of (6)
  3. GSK Faculty (3)
  4. Human Oncology and Pathogenesis Program (3)
  5. Tow Center for Developmental Oncology (TCDO) (3)
  6. Biostatistics Service (2)
  7. Epidemiology and Biostatistics (2)
  8. Department of Medicine (1)
  9. Medical Physics (1)
  10. Multidisciplinary Brain Metastasis Program (1)
  1. "Robert Young"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Neuroradiology Service (6)
  2. Radiology, Department of (6)
  3. GSK Faculty (3)
  4. Human Oncology and Pathogenesis Program (3)
  5. Tow Center for Developmental Oncology (TCDO) (3)
  6. Biostatistics Service (2)

More Groups

People
  1. Robert Young (6)
  2. Ingo Mellinghoff (3)
  3. Mariza Daras (2)
  4. Ai Ni (1)
  5. Christopher Rodriguez (1)
  6. Gregory Riely (1)

More People

Years
  1. 2018 (1)
  2. 2017 (4)
  3. 2012 (1)
Publications
  1. Neuro-Oncology (4)
  2. Cancer (1)
  3. Neurology (1)
Publishers
  1. Oxford University Press (4)
  2. Lippincott Williams & Wilkins (1)
  3. Wiley Blackwell (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
    Journal Article

    Arbour, K. C.; Kris, M. G.; Riely, G. J.; Ni, A.; Beal, K.; Daras, M.; Hayes, S. A.; Young, R. J.; Rodriguez, C. R.; Ahn, L.; more...
    Cancer (2018)

    Fulltext@MSK | Save
  • Use of dynamic contrast enhanced MRI in predicting response to immunotherapy in patients with recurrent high grade glioma
    Meeting Abstract

    Nevel, K.; Schreyer, M.; Panageas, K.; Young, R. J.; Daras, M.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Post-surgical, residual enhancing tumor volume is prognostic for overall survival in newly diagnosed glioblastoma: Evidence from 1,458 patients pooled from international trials, single institution databases, and multicenter consortiums
    Meeting Abstract

    Ellingson, B.; Abrey, L.; Nelson, S.; Garcia, J.; Chinot, O.; Saran, F.; Nishikawa, R.; Henriksson, R.; Mason, W.; Wick, W.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Volumetric analysis of IDH-mutant low-grade glioma: A natural history study of tumor growth rates before and after treatment
    Meeting Abstract

    Huang, R.; Young, R. J.; Ellingson, B.; Veeraraghavan, H.; Wang, W.; Luks, T.; Kim, J.; Gerstner, E.; Schiff, D.; Peters, K. B.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • AG-120, a first-in-class mutant IDH1 inhibitor in patients with recurrent or progressive IDH1 mutant glioma: Updated results from the phase 1 non-enhancing glioma population
    Meeting Abstract

    Mellinghoff, I. K.; Touat, M.; Maher, E.; De La Fuente, M.; Cloughesy, T. F.; Holdhoff, M.; Cote, G. M.; Burris, H.; Janku, F.; Huang, R.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • An unusual cause of isolated vomiting
    Journal Article

    Wang, T. J.; Lee, N. Y.; Young, R. J.
    Neurology (2012)

    Fulltext@MSK | Save